Take a look at the businesses making headlines earlier than the bell.

Intel — Shares popped 2.5% after the chipmaker introduced it might be working its programmable chip unit as a stand-alone enterprise. Intel plans to conduct an preliminary public providing for the unit throughout the subsequent two to 3 years.

Fluor — Shares climbed 2.4% following an improve to purchase at UBS. The agency is bullish on the inventory because of progress on legacy tasks and stated Fluor is getting ready to an organization turning level. 

Apple — The iPhone maker shed 0.9% after KeyBanc minimize its ranking on Apple to sector weight from obese late Tuesday, citing shares’ excessive valuation and an expectation for tender development within the U.S.

Sunrun, Sunnova Power Worldwide — Shares of Sunrun and Sunnova dropped 3% and a couple of.8%, respectively, after Truist Securities downgraded the photo voltaic panel installers to carry from purchase Wednesday. The agency stated higher-for-longer rates of interest may hit photo voltaic vitality shares.

Moderna — The pharma inventory rose barely after Moderna introduced constructive interim outcomes from the Part 1/2 trial of mRNA-1083, an investigational mixture vaccine in opposition to influenza and Covid. Moderna stated in a press launch it plans to start a Part 3 trial of the mix vaccine in 2023, working to perform potential regulatory approval in 2025.

Oddity — The Israel-based magnificence inventory, which owns direct-to-consumer manufacturers Il Makiage and SpoiledChild, added 3.2% after Financial institution of America upgraded it to purchase from impartial. The financial institution stated it expects sustainable annual gross sales development and margin growth.

Novartis — Shares misplaced 3.7% after the Swiss drugmaker accomplished the spinoff of its generics and biosimilars enterprise Sandoz, which dipped on its market debut on the SIX Swiss Trade.

Cal-Maine Meals — The inventory plunged 11.6% after the corporate got here out with disappointing gross sales figures because of decrease costs. The egg producer reported fiscal first-quarter earnings of two cents per share, whereas analysts polled by StreetAccount had referred to as for earnings of 33 cents per share. Income was additionally lackluster.

— CNBC’s Brian Evans and Lisa Han contributed reporting.